Dudediligence.

Krystal Biotech, Inc

KRYSNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Results of operationsAug 3 →InsidersNo open-market buys. 6 insiders sold $78.7M, 105 of 107 sales on a 10b5-1 plan.→HoldersFMR 14.9%BlackRock 14.1%Avoro Capital 9.8%→PeersClosest companies: OCGN, VRDN, QURE→

From the filings

Figures

Revenue
$440.5Mlast 12 months
Net income
$241.5Mlast 12 months
Operating cash flow
$250.3Mlast 12 months
Cash and equivalents
$427.7Mat the last balance sheet
Shares outstanding
29.6M shareson issue
Every year and quarter →